Jessica Simpson retail Web site
This article was originally published in The Rose Sheet
Executive Summary
Delivery Agent, Inc. has struck a deal with JT Entertainment to create a Web destination at 1www.SeenOn.com that provides "personal shopper" access to musical artist and entertainer Jessica Simpson, according to an Aug. 20 announcement. The site allows fans to purchase more than 500 products associated with Simpson and her celebrity lifestyle, including clothing, accessories and her upcoming fragrance line from Parlux (2"The Rose Sheet" July 2, 2007, In Brief). "Simpson fans will be able to easily identify and click to purchase products they have seen on the star in photographs as well as through Shopisodes, an online video application that allows consumers to synchronously shop for the items as they watch the video," Delivery Agent explains, noting that its involvement in the "personality branded products arena" will increase with "additional A-list talent deals expected in the coming months." Simpson currently markets the Dessert Beauty by Jessica Simpson bath and body care line; her signature fragrance with Parlux is slated to debut in July 2008...
You may also be interested in...
Parlux partners with Simpson
Singer/actress Jessica Simpson partners with Parlux Fragrances and the Camuto Group to launch her first signature fragrance, the companies announce June 26. Designed to "reflect Simpson's style, personality and confidence," the fragrance line will debut in the U.S. in July 2008, with an international roll-out shortly thereafter, firms say. "Fragrance is a natural product expansion for the Jessica Simpson lifestyle brand," Camuto Group CEO Vince Camuto says. Simpson currently markets clothing, footwear and the Dessert Beauty by Jessica Simpson line of bath and body care. Parlux manufactures and distributes fragrances by Paris Hilton, GUESS?, Andy Roddick, babyGund, and Fred Hayman Beverly Hills, among others...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.